M H Adelman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M H Adelman

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Drug Intelligence & Clinical Pharmacy|July 1, 1983

A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic modelJ J Schentag, M H Adelman

DICP : the Annals of Pharmacotherapy|October 1, 1991

Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycinJ J Schentag, D E Nix, M H Adelman

Pharmacotherapy|January 1, 1987

Determinants of antibiotic-associated hypoprothrombinemiaJ J Schentag, L S Welage, T H Grasela, et al.

Antimicrobial Agents and Chemotherapy|April 1, 1987

Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteersN E Winslade, M H Adelman, E J Evans, et al.

The Journal of Laboratory and Clinical Medicine|August 1, 1982

Renal handling of gentamicin by normal and ischemic canine kidneysM H Adelman, N J Harrison, P B Wels, et al.

American Journal of Surgery|May 31, 1988

Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moietyJ J Schentag, L S Welage, J S Williams, et al.

Infection Control and Hospital Epidemiology|April 1, 1997

Changing the infection control paradigm from off-line to real time: the experience at Millard Fillmore Health SystemJ R Carr, P Fitzpatrick, J L Izzo, et al.

Seminars in Respiratory Infections|January 22, 1998

In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistanceJ J Schentag, M C Birmingham, J A Paladino, et al.

Diagnostic Microbiology and Infectious Disease|March 1, 1993

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratoryJ J Schentag, C H Ballow, A L Fritz, et al.

Pageof 1

Search research articles

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Drug Intelligence & Clinical Pharmacy|July 1, 1983

A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic modelJ J Schentag, M H Adelman

DICP : the Annals of Pharmacotherapy|October 1, 1991

Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycinJ J Schentag, D E Nix, M H Adelman

Pharmacotherapy|January 1, 1987

Determinants of antibiotic-associated hypoprothrombinemiaJ J Schentag, L S Welage, T H Grasela, et al.

Antimicrobial Agents and Chemotherapy|April 1, 1987

Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteersN E Winslade, M H Adelman, E J Evans, et al.

The Journal of Laboratory and Clinical Medicine|August 1, 1982

Renal handling of gentamicin by normal and ischemic canine kidneysM H Adelman, N J Harrison, P B Wels, et al.

American Journal of Surgery|May 31, 1988

Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moietyJ J Schentag, L S Welage, J S Williams, et al.

Infection Control and Hospital Epidemiology|April 1, 1997

Changing the infection control paradigm from off-line to real time: the experience at Millard Fillmore Health SystemJ R Carr, P Fitzpatrick, J L Izzo, et al.

Seminars in Respiratory Infections|January 22, 1998

In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistanceJ J Schentag, M C Birmingham, J A Paladino, et al.

Diagnostic Microbiology and Infectious Disease|March 1, 1993

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratoryJ J Schentag, C H Ballow, A L Fritz, et al.

Pageof 1